Sanguine Capital Revenue and Competitors
Estimated Revenue & Valuation
- Sanguine Capital's estimated annual revenue is currently $2.6M per year.
- Sanguine Capital's estimated revenue per employee is $98,000
Employee Data
- Sanguine Capital has 27 Employees.
- Sanguine Capital grew their employee count by 13% last year.
Sanguine Capital's People
Name | Title | Email/Phone |
---|
Sanguine Capital Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3.7M | 33 | N/A | N/A | N/A |
#2 | $17.6M | 126 | 48% | N/A | N/A |
#3 | $165.1M | 0 | N/A | N/A | N/A |
#4 | $22M | 178 | 11% | $60.4M | N/A |
#5 | $15.8M | 113 | -18% | $3M | N/A |
#6 | $0.3M | 4 | N/A | N/A | N/A |
#7 | $2.1M | 21 | 11% | N/A | N/A |
#8 | $8.8M | 72 | -12% | $16.9M | N/A |
#9 | $3.7M | 33 | 3% | N/A | N/A |
#10 | $4M | 63 | 5% | N/A | N/A |
What Is Sanguine Capital?
Our Mission is to improve the health of Clients Wealth.
keywords:N/AN/A
Total Funding
27
Number of Employees
$2.6M
Revenue (est)
13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sanguine Capital News
2022-04-20 - The IMFs updated view on capital controls: Welcome fixes but major
rethinking is still needed
By the time of the onset of the Global Financial Crisis (GFC), the IMF took a sanguine view of the capital controls being put in place by...
2022-04-17 - The capital of chile is
The self-proclaimed Chile Capital of the World is a small farming ... newspaper described him as a young man of sanguine temperament,...
2022-04-06 - Analysis: With capital markets jittery, private equity pounces to ...
Others are more sanguine, pointing out that the private equity firms are providing loans that banks would not have been allowed to extend in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.4M | 28 | 8% | N/A |
#2 | $7.2M | 29 | 7% | N/A |
#3 | N/A | 29 | 12% | N/A |
#4 | $1.2M | 29 | 38% | N/A |
#5 | N/A | 32 | 23% | N/A |